ShareValue scores for VIVIMEDLAB.NSE: Valuation 72, Quality 30, Growth 36, Health 32.

VIVIMEDLAB.NSE
NSE

Vivimed Labs Limited

₹5.15(+4.89%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

9% to 29%
Valuation
72
Undervalued
Price vs Value
Quality
30
Weak
Business Strength
Growth
36
Weak
Revenue & Earnings
Health
32
Stressed
Financial Stability
Momentum
51
Neutral
Price Trend

Company Details

About

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 18, 2026
|
Last calculated:Aug 18, 2026